Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001698530-25-000019
Filing Date
2025-03-18
Accepted
2025-03-18 16:23:32
Documents
92
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K xcur-20241231.htm   iXBRL 10-K 1324258
2 EX-23.1 exicureexhibit231123124.htm EX-23.1 2991
3 EX-31.1 exicureexhibit311-123124.htm EX-31.1 7744
4 EX-31.2 exicureexhibit312-123124.htm EX-31.2 7759
5 EX-32.1 exicureexhibit321-123124.htm EX-32.1 8223
  Complete submission text file 0001698530-25-000019.txt   7485133

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20241231.xsd EX-101.SCH 62716
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xcur-20241231_cal.xml EX-101.CAL 80869
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xcur-20241231_def.xml EX-101.DEF 237924
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20241231_lab.xml EX-101.LAB 744728
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20241231_pre.xml EX-101.PRE 526203
95 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20241231_htm.xml XML 788876
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39011 | Film No.: 25748709
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)